From: Microrna-124 targets flotillin-1 to regulate proliferation and migration in breast cancer
Clinicopathologic parameters | Number of cases | Median expression of miR-124 | P-value |
---|---|---|---|
Age (year) | Â | Â | Â |
≤45 | 38 | 0.4252 ± 0.0403 | 0.0372 |
>45 | 40 | 0.3140 ± 0.0338 | |
Tumor size (cm) | Â | Â | Â |
≤2 | 25 | 0.4107 ± 0.0573 | 0.2781 |
>2 | 53 | 0.3481 ± 0.0287 | |
TNM stage | Â | Â | Â |
I + II | 62 | 0.4128 ± 0.0307 | 0.0007 |
III + IV | 16 | 0.1951 ± 0.0231 | |
Lymph node metastasis | Â | Â | Â |
No | 41 | 0.4550 ± 0.0407 | 0.0004 |
Yes | 37 | 0.2720 ± 0.0265 | |
ER status | Â | Â | Â |
Negative | 25 | 0.3575 ± 0.0495 | 0.7861 |
Positive | 53 | 0.3732 ± 0.0320 | |
PR status | Â | Â | Â |
Negative | 31 | 0.3426 ± 0.0395 | 0.4423 |
Positive | 47 | 0.3850 ± 0.0361 | |
Her2 status | Â | Â | Â |
Negative | 49 | 0.3548 ± 0.0326 | 0.5221 |
Positive | 29 | 0.3906 ± 0.0469 |  |